1. Home
  2. TWST vs CHCO Comparison

TWST vs CHCO Comparison

Compare TWST & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • CHCO
  • Stock Information
  • Founded
  • TWST 2013
  • CHCO 1957
  • Country
  • TWST United States
  • CHCO United States
  • Employees
  • TWST N/A
  • CHCO N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • CHCO Major Banks
  • Sector
  • TWST Health Care
  • CHCO Finance
  • Exchange
  • TWST Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • TWST 2.3B
  • CHCO 1.8B
  • IPO Year
  • TWST 2018
  • CHCO N/A
  • Fundamental
  • Price
  • TWST $28.84
  • CHCO $123.11
  • Analyst Decision
  • TWST Buy
  • CHCO Hold
  • Analyst Count
  • TWST 10
  • CHCO 3
  • Target Price
  • TWST $49.10
  • CHCO $132.33
  • AVG Volume (30 Days)
  • TWST 1.8M
  • CHCO 103.5K
  • Earning Date
  • TWST 08-04-2025
  • CHCO 07-22-2025
  • Dividend Yield
  • TWST N/A
  • CHCO 2.54%
  • EPS Growth
  • TWST N/A
  • CHCO 6.95
  • EPS
  • TWST N/A
  • CHCO 8.30
  • Revenue
  • TWST $362,273,000.00
  • CHCO $300,872,000.00
  • Revenue This Year
  • TWST $22.75
  • CHCO $9.69
  • Revenue Next Year
  • TWST $17.63
  • CHCO $1.71
  • P/E Ratio
  • TWST N/A
  • CHCO $14.99
  • Revenue Growth
  • TWST 22.72
  • CHCO 4.61
  • 52 Week Low
  • TWST $24.28
  • CHCO $102.22
  • 52 Week High
  • TWST $55.33
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • TWST 39.95
  • CHCO 50.86
  • Support Level
  • TWST $24.28
  • CHCO $118.72
  • Resistance Level
  • TWST $31.20
  • CHCO $124.49
  • Average True Range (ATR)
  • TWST 1.97
  • CHCO 2.59
  • MACD
  • TWST -0.34
  • CHCO -0.09
  • Stochastic Oscillator
  • TWST 35.51
  • CHCO 50.63

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: